SNYDER CAPITAL MANAGEMENT L P
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1050477
San Francisco, CA
Position in TMO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$48,003,311
-$17,394,574 QoQ
Shares Held
97,661
-13.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SNYDER CAPITAL MANAGEMENT L P holds $89,007,423 across 2 Diagnostics & Research names. TMO ranks #1 (53.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
97,661 | $48,003,311 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
237,705 | $41,004,112 |
All Filings in TMO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,003,311 | 97,661 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $65,397,885 | 112,862 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $47,670,190 | 98,285 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $23,227,992 | 57,288 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $23,065,252 | 46,353 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,043,990 | 46,218 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,181,039 | 47,175 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,947,640 | 37,880 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||